170 related articles for article (PubMed ID: 31552839)
1. Wonder drug for worms: A review of three decades of ivermectin use in dermatology.
Gowtham S; Karthikeyan K
Indian J Dermatol Venereol Leprol; 2019; 85(6):674-678. PubMed ID: 31552839
[No Abstract] [Full Text] [Related]
2. Ivermectin in dermatology.
del Giudice P; Chosidow O; Caumes E
J Drugs Dermatol; 2003 Jan; 2(1):13-21. PubMed ID: 12852376
[TBL] [Abstract][Full Text] [Related]
3. Persistent coma in Strongyloides hyperinfection syndrome associated with persistently increased ivermectin levels.
van Westerloo DJ; Landman GW; Prichard R; Lespine A; Visser LG
Clin Infect Dis; 2014 Jan; 58(1):143-4. PubMed ID: 24065325
[No Abstract] [Full Text] [Related]
4. [Indication of Mectizan in human medicine other than onchocerciasis].
Richard-Lenoble D
Sante; 1998; 8(1):84-7. PubMed ID: 9592892
[No Abstract] [Full Text] [Related]
5. Ivermectin: pharmacology and application in dermatology.
Dourmishev AL; Dourmishev LA; Schwartz RA
Int J Dermatol; 2005 Dec; 44(12):981-8. PubMed ID: 16409259
[TBL] [Abstract][Full Text] [Related]
6. [A Nobel Prize in Medicine 2015 for tropical countries: ivermectin, an antiparasitic drug undeniable against filariasis].
Danis M; Richard-Lenoble D
Med Sci (Paris); 2016 Jan; 32(1):110-5. PubMed ID: 26850616
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis.
Igual-Adell R; Oltra-Alcaraz C; Soler-Company E; Sánchez-Sánchez P; Matogo-Oyana J; Rodríguez-Calabuig D
Expert Opin Pharmacother; 2004 Dec; 5(12):2615-9. PubMed ID: 15571478
[TBL] [Abstract][Full Text] [Related]
8. Disseminated Strongyloides stercoralis infection with a cutaneous presentation in an immunosuppressed patient.
Benvenuti F; Carrascosa JM; Boada A; Ferrandiz C
Eur J Dermatol; 2009; 19(4):404-5. PubMed ID: 19467975
[No Abstract] [Full Text] [Related]
9. Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock.
Salluh JI; Feres GA; Velasco E; Holanda GS; Toscano L; Soares M
Intensive Care Med; 2005 Sep; 31(9):1292. PubMed ID: 16041520
[No Abstract] [Full Text] [Related]
10. Lymphatic filariasis.
Prescrire Int; 2008 Feb; 17(93):36. PubMed ID: 18383658
[TBL] [Abstract][Full Text] [Related]
11. Antiparasitic activity of ivermectin: Four decades of research into a "wonder drug".
Sulik M; Antoszczak M; Huczyński A; Steverding D
Eur J Med Chem; 2023 Dec; 261():115838. PubMed ID: 37793327
[TBL] [Abstract][Full Text] [Related]
12. [New indications of ivermectin].
Caumes E; Danis M
Rev Med Interne; 2001 Apr; 22(4):379-84. PubMed ID: 11586522
[TBL] [Abstract][Full Text] [Related]
13. Treatment of stephanofilariosis ('earsore') with ivermectin.
Gill BS; Balakrishnan P; Lumsden GG; Jones PG
Vet Parasitol; 1991 Oct; 40(1-2):159-63. PubMed ID: 1763486
[TBL] [Abstract][Full Text] [Related]
14. Flare-up reaction after creeping disease.
Ono M; Koba S; Hisatomi M; Misago N; Narisawa Y
Australas J Dermatol; 2013 Nov; 54(4):e98-9. PubMed ID: 24164186
[No Abstract] [Full Text] [Related]
15. Ivermectin for scabies and headlice: veterinary use only.
Lowenthal MN
Isr Med Assoc J; 2013 May; 15(5):262. PubMed ID: 23841255
[No Abstract] [Full Text] [Related]
16. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
Marty FM; Lowry CM; Rodriguez M; Milner DA; Pieciak WS; Sinha A; Fleckenstein L; Baden LR
Clin Infect Dis; 2005 Jul; 41(1):e5-8. PubMed ID: 15937753
[TBL] [Abstract][Full Text] [Related]
17. Ivermectin lotion (sklice) for head lice.
Early J; MacNaughton H
Am Fam Physician; 2014 Jun; 89(12):984-6. PubMed ID: 25162168
[No Abstract] [Full Text] [Related]
18. Non-oral treatment with ivermectin for disseminated strongyloidiasis.
Fusco DN; Downs JA; Satlin MJ; Pahuja M; Ramos L; Barie PS; Fleckenstein L; Murray HW
Am J Trop Med Hyg; 2010 Oct; 83(4):879-83. PubMed ID: 20889884
[TBL] [Abstract][Full Text] [Related]
19. [Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use].
Manrique-Rodríguez S; Martín-Rabadán P; Díaz-Cámara M; Fernández-Llamazares CM
Med Clin (Barc); 2016 Apr; 146(8):376-7. PubMed ID: 26654554
[No Abstract] [Full Text] [Related]
20. Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg?
Wilkins AL; Steer AC; Cranswick N; Gwee A
Arch Dis Child; 2018 May; 103(5):514-519. PubMed ID: 29463522
[No Abstract] [Full Text] [Related]
[Next] [New Search]
